Mantle cell lymphomas lack expression of p27(kip1), a cyclin-dependent kinase inhibitor

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 175-182

  Quintanilla Martinez, Leticia ^a   Thieblemont, Catherine ^a   Fend, Falko ^a   Kumar, Shimareet ^a   Pinyol, Magda ^b   Campo, Elias ^b   Jaffe, Elaine S ^a   Raffeld, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P27;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0031846504     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65558-7     Document Type: Article

References (40)

1. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
2. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 9:1149-1163
3. KIP-1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66
4. Kato J, Matsuoka M, Polyak K, Massague J, Sherr CJ: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27KIP1) of cyclin-dependent kinase 4 activation. Cell 1994, 79:487-496
5. KIP-1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573
6. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E: Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 1996, 271:499-502
7. KIP-1, a cyclin-dependent kinase inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22
8. KIP-1. Cell 1996, 85:721-732
9. KIP1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720
10. KIP1-deficient mice. Cell 1996, 85:733-744
11. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995, 86:841-854
12. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27 KIP-1. Genes Dev 1997, 11:1464-1478
13. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin dependent kinase inhibitor p27. Science 1995, 269:682-685
14. Hengst L, Reed SI: Translational control of p27 KIP-1 accumulation during the cell cycle. Science 1996, 271:1861-1864
15. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74
16. KIP-1, to regions involved in human cancer. Cancer Res 1995, 55:1199-1205
17. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR, Koeffler HP: Molecular analysis of the cyclin-dependent kinase inhibitor p27/KIP-1 in human malignancies. Cancer Res 1995, 55:2266-2269
18. KIP-1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995, 55:1206-1210
19. KIP-1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995, 55:1211-1214
20. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997, 3:231-234
21. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell-cycle regulators p27Kip-1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997, 3:222-225
22. 1a,b) invasive breast carcinomas. Cancer Res 1997, 57:1259-1263
23. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D HP, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X: High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27Kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997, 94:6380-6385
24. Kumar S, Krenacs L, Otsuki T, Kumar D, Harris CA, Wellmann A, Jaffe ES, Raffeld M: bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 1996, 105:737-743
25. Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M: Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 1997, 89:601-609
26. Waf1 genes are associated with aggressive variants of Mantle cell lymphomas. Blood 1997, 89:272-280
27. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
28. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES: Lymphocytic lymphoma of intermediate differentiation: morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990, 14:752-761
29. Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Müller JG, Müller-Hermelink HK: Blastoid variant of Mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 1997, 89:1421-1429
30. Ott MM, Ott G, Porowski P, Gunzer U, Feller AC, Müller-Kermelink HK: The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 1994, 25:329-336
31. Kip1 expression in inversely proportional to the proliferative index. Am J Pathol 1997, 151:151-160
32. Kip1 for restriction point control of the fibroblast cell cycle. Science 1996, 272:877-880
33. Reynisdóttir I, Massagué J: The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 1997, 11:492-503
34. Jiang W, Kahn SM, Zhou P, Zhang Y-J, Cacace AM, Infante AS, Doi S, Saantella RM, Weinstein IB. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993, 8:3447-3457
35. Quelle DE, Ashmun RA, Shurleff SA, Kato J, Bar-Sagi D, Roussel M, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571
36. Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994, 9:323-326
37. Lovec H, Grzeschiczek A, Kowalski MB, Möröy T: Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994, 13:3487-3495
38. Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M: p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996, 87:3351-3359
39. Kip1 in human breast cancers. Clin Cancer Res 1997, 3:1879-1887
40. Kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 1996, 7:699-710